SEROTONERGIC STIMULATION OF THE VENTROLATERAL STRIATUM INDUCES OROFACIAL STEREOTYPY

Citation
Sk. Yeghiayan et Ae. Kelley, SEROTONERGIC STIMULATION OF THE VENTROLATERAL STRIATUM INDUCES OROFACIAL STEREOTYPY, Pharmacology, biochemistry and behavior, 52(3), 1995, pp. 493-501
Citations number
73
Categorie Soggetti
Pharmacology & Pharmacy","Pharmacology & Pharmacy
ISSN journal
00913057
Volume
52
Issue
3
Year of publication
1995
Pages
493 - 501
Database
ISI
SICI code
0091-3057(1995)52:3<493:SSOTVS>2.0.ZU;2-M
Abstract
Dopaminergic (DA) stimulation of the ventrolateral striatum produces a syndrome of intense orofacial stereotypies. In addition to dopaminerg ic projections from the substantia nigra, the striatum receives seroto nergic (5-HT) inputs arising from the raphe nuclei. To assess the puta tive role of striatal 5-HT in orofacial movements, serotonin (0, 0.2, 2, 10, 20 mu g/1.0 mu l) was infused into the ventrolateral striatum a nd behaviors were recorded using a time-sampling procedure. Serotonin produced a dose-dependent, site-specific increase in stereotyped orofa cial behaviors. Infusion of selective 5-HT receptor agonists or uptake inhibitors did not produce the orofacial syndrome and pretreatment wi th either selective or nonselective 5-HT receptor antagonists did not block the 5-HT induced stereotypy. In contrast, pretreatment with DA r eceptor antagonists completely abolished the 5-HT induced repetitive o rofacial movements, providing evidence for a 5-HT/DA interaction at th is site. Moreover, depletion of DA with a combination of reserpine and alpha-methyl-p-tyrosine markedly decreased the stereotyped behaviors induced by 5-HT microinfusion. These data provide evidence for an inte raction between 5-HT and DA in the striatum at presynaptic DA terminal s. It is hypothesized that 5-HT may cause release of DA via reversal o f the DA transporter. This syndrome may provide an animal model for so me aspects of obsessive-compulsive disorder, because current theories of this disorder implicate 5-HT dysfunction in the basal ganglia.